Markets:

Overview

News

Currencies

International

Treasuries

Moderna, Inc. - Common Stock (NQ:MRNA)

25.98 UNCHANGED

Streaming Delayed Price Updated: 1:00 PM EST, Nov 28, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Moderna, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Moderna Stands By UK As Pharma Giants Criticize Pricing, UK Secures First Onshore mRNA Vaccine Production Centre ↗

September 25, 2025

Moderna, Inc.‘s (NASDAQ: MRNA) UK chief Darius Hughes defended Britain's drug pricing policies after the country was branded the "worst in Europe."

Via Benzinga

Moderna Opens State-of-the-Art Manufacturing and R&D Facility in the UK

September 24, 2025

Via ACCESS Newswire

Flagship Pioneering, Creator Of Moderna, Launches Extuitive With $20M To Reinvent Consumer Products Using AI Shoppers ↗

September 23, 2025

Via Benzinga

Topics Artificial Intelligence

Moderna's COVID-19 Vaccine Update Boosts Antibodies 16-Fold, Data Shows ↗

September 23, 2025

Moderna's 2025-2026 mNEXSPIKE showed strong immune response and safety in Phase 4 trials, reinforcing FDA approval for the LP.8.1-targeting formula.

Via Benzinga

Stocks making big moves yesterday: Plug Power, Moderna, Magnite, Compass, and RE/MAX

September 23, 2025

Check out the companies making headlines yesterday:

Via StockStory

Moderna Says Updated mNEXSPIKE Covid Shot Demonstrated Robust Immune Response In Study ↗

September 23, 2025

Via Stocktwits

Is Moderna Gaining or Losing Market Support? ↗

September 22, 2025

Via Benzinga

Moderna Announces mNEXSPIKE Generates Strong Immune Response Against LP.8.1 Variant in Humans

September 23, 2025

Via ACCESS Newswire

Trump Advises Parents To Split Vaccines, Delay Hepatitis B Shots Until Age 12: 'This Is Based On What I Feel' ↗

September 22, 2025

President Donald Trump on Monday offered advice on childhood vaccination schedules, encouraging parents to split up certain immunizations and delay certain others, in sharp contradiction to current...

Via Benzinga

Topics Government

Why Moderna (MRNA) Stock Is Trading Up Today

September 22, 2025

Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 6.1% in the afternoon session after the company announced it delivered the first mRNA vaccines fully manufactured in Canada to the nation's...

Via StockStory

Which S&P500 stocks are moving on Monday? ↗

September 22, 2025

Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Monday.

Via Chartmill

Stocks Extend Records, Gold Soars To $3,740: What's Moving Markets Monday? ↗

September 22, 2025

Wall Street is on track for its third straight day of gains, with major large-cap indices extending records as investors remain optimistic about corporate earnings and upcoming rate cuts.

Via Benzinga

Top S&P500 movers in Monday's session ↗

September 22, 2025

Stay informed about the performance of the S&P500 index in the middle of the day on Monday. Uncover the top gainers and losers in today's session for valuable insights.

Via Chartmill

3 of Wall Street’s Favorite Stocks with Open Questions

September 22, 2025

Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional...

Via StockStory

CDC Ends Universal Covid Vaccine Recommendation; Moderna Skids ↗

September 19, 2025

Moderna stock toppled Friday after advisors to the CDC and Prevention ended the universal recommendation for Covid vaccines.

Via Investor's Business Daily

Moderna Announces First Made-in-Canada mRNA Vaccines Delivered to Canadian Provinces and Territories

September 19, 2025

Via ACCESS Newswire

Elizabeth Warren Says Measles Can Hit Record Highs, Slams RFK Jr.'s CDC Panel For Delaying Vaccine: 'How Does That Keep Our Kids Safe?' ↗

September 18, 2025

Sen. Elizabeth Warren (D-Mass.) on Thursday criticized the Centers for Disease Control and Prevention's vaccine advisory panel following its controversial vote to delay the combined measles, mumps,...

Via Benzinga

The Battle Over Covid Vaccines Hits A Fever Pitch As RFK-Picked Panel Makes Its Debut ↗

September 18, 2025

The reworked ACIP will make its debut Friday when the panelists weigh the suite of new Covid boosters.

Via Investor's Business Daily

Topics Government

3 Small-Cap Stocks with Questionable Fundamentals

September 18, 2025

Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small...

Via StockStory

What's Going On With Moderna Stock Wednesday? ↗

September 17, 2025

Moderna shares are trading marginally lower Wednesday morning. Tuesday's rally was driven by the release of positive preliminary data for its updated 2025-2026 Spikevax formula.

Via Benzinga

Nio, Rivian, Moderna, Meta And Bitmine Immersion: Why These 5 Stocks Are On Investors' Radars Today ↗

September 16, 2025

On Tuesday, U.S. markets slipped, with the Dow Jones Industrial Average falling about 0.3% to 45,757.90, the S&P 500 retreating 0.1% to 6,606.76, and the Nasdaq edging down 0.07% to 22,333.96.These are...

Via Benzinga

Topics Stocks

Moderna Stock Is Moving Higher Tuesday: Here's Why ↗

September 16, 2025

Moderna, Inc. (NASDAQ:MRNA) shares are up nearly 5% on Tuesday after the company announced positive preliminary immunogenicity data for its 2025-2026 Spikevax formula, which targets the new LP.8.1...

Via Benzinga

Explore the top gainers and losers within the S&P500 index in today's session. ↗

September 16, 2025

Stay informed about the performance of the S&P500 index one hour before the close of the markets on Tuesday. Uncover the top gainers and losers in today's session for valuable insights.

Via Chartmill

Tuesday's session: top gainers and losers in the S&P500 index ↗

September 16, 2025

Curious about the S&P500 stocks that are in motion on Tuesday? Join us as we explore the top movers within the S&P500 index during today's session.

Via Chartmill

Why Moderna (MRNA) Stock Is Trading Up Today

September 16, 2025

Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 4% in the morning session after the company announced positive preliminary data for its updated 2025-2026 COVID-19 vaccine, Spikevax®.

Via StockStory

Topics Death Government

Moderna Reports 8-Fold Jump In Antibodies With Updated Spikevax ↗

September 16, 2025

Moderna's updated Spikevax shows strong antibody response and safety, targeting dominant COVID-19 variants like LP.8.1 in high-risk and older adults.

Via Benzinga

Moderna Announces Updated COVID-19 Vaccine Against LP.8.1 Variant Generates Strong Immune Response in Humans

September 16, 2025

Via ACCESS Newswire

Robert Kennedy Jr. Packs CDC Panel With Vaccine Skeptics Ahead of Key Vote On COVID-19 Shots ↗

September 15, 2025

Health and Human Services Secretary Robert F. Kennedy Jr. has added five new members to the Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices, just days...

Via Benzinga

Oracle Retreats, Fed Rate Cut Looms, and Vaccine Politics Shake Pharma Stocks ↗

September 15, 2025

Markets closed Friday in mixed fashion as economic uncertainty and politics clashed with earnings optimism. Oracle's rollercoaster continues, RFK Jr. rattles vaccine makers, and the Fed appears poised...

Via Chartmill

Topics Artificial Intelligence Economy

Why Moderna (MRNA) Shares Are Trading Lower Today

September 12, 2025

Shares of biotechnology company Moderna (NASDAQ:MRNA) fell 7.8% in the afternoon session after reports revealed Trump administration health officials plan to link COVID-19 vaccines to the deaths of...

Via StockStory

Topics Death Government

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.